We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
These guys got a bit excited yesterday, upped their short by 0.1%
Don't disagree with you Fredster that a rate cut or 2 wouldn't do any harm to prospects
Not quite favourable macros yet I think we need to interest rates come down here and across the pond when there will be more appetite for this type of stock. That said I don’t think it’s too far away.
Maybe not before the AGM, but I'm with crafty. Rightly or wrongly, MM hates it on the LSE, and has been very vocal that he thinks it is the wrong place for THG. He has been biding his time to get some better numbers/forecasts out, get cashflow into a better position, and await more friendly macro/financing conditions. With those conditions now in place, he has to pull the trigger on something sooner rather than later to get to a more favourable valuation for shareholders and retain support, and give him a platform to accelerate growth again. JMO
Fair price is 175. Because share quantity increase over 35%. 1.3b shares. I can not image over 200
Fair enough. I'm not convinced that anything will happen in the near term, but let's see.
Great Crafty, keep up the good work.
Yep IMHO it has to happen before AGM or at least update on a review to list on a different exchange and if there is percentage equity interest in one or more of the divisions he will let the market know.
Why spend 15M separating the 3 divs and then do SFA.
Interesting to see who the new ingeniuty appointment will be on the 1st June. MM seemed very excited about that :)
No comment from them thus far after todays rns
Hmm thats true isn't it? @Crafty - are you still expecting a "major event" from now until the AGM in order for MM and BOD to remain in their positions? I recall you repeatedly saying that something has to happen otherwise they will lose support.
Nothing "major" has happened yet and they all seem to be sitting reasonably pretty.
You said you wouldn't be back till the AGM rampy. What happened?
Thank you crafty 👍
As for the green box remark, be my guest, I have no time for people who reside in echo chambers
"unless you are prepared to wait 5 - 10 years"
Can't speak for the horizon of others but an 8-10 bagger over 5-10 years certainly beats inflation 🤔 I'd be reasonably content with that outcome.
Yespsb you promised 'out' as soon as SP hits 70s, twice since it has hit 70p.
Did you forget to set your sell order?
Next time we hit 70p I will remind you :)
Well done!!!.. yspb you have been awarded a Green box for a great post
Beauty markets are buoyant and thriving away from LSE
https://beautymatter.com/articles/galderma-stock-surges-in-debut
EQT AB–backed Swiss skincare company Galderma surged on its first day of trading, trading as high as 18% to 62.68 francs. It was the largest IPO placement volume in Switzerland since 2017 and could be one of the biggest flotations in Europe this year.
WHO: Galderma is the world's largest independent dermatology company, spun out of Nestlé in 2019 when a consortium led by private equity house EQT and including Singapore's GIC and the Abu Dhabi Investment Authority acquired the Nestlé Skin Health unit for $10 billion and rebranded it as Galderma. Since its inception in 1981, the business has been driven by a dedication to dermatology, delivering an innovative, science-based portfolio of sophisticated brands and services across aesthetics, consumer care, and prescription medicine. Galderma’s portfolio of flagship brands includes Restylane, Dysport, Azzalure, Alluzience, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac and Loceryl in therapeutic dermatology.
WHY: Sale is success for EQT, which had eyed an IPO since 2021; Galderma plans to repay debt with the offering proceeds.
IN THEIR OWN WORDS: Flemming Ørnskov, MD, MPH, Chief Executive Officer of Galderma, said, “As the newest member of SIX Swiss Exchange, I am proud that Galderma’s IPO has been such a success. Galderma has continually developed its market leading position by advancing dermatology for every skin story. As we begin trading today, I want to thank every single person in our business for their unwavering commitment over the years—without it, Galderma wouldn’t have achieved the success we have to date. We have a great future ahead of us as a listed company delivering cutting-edge, premium products to our customers across the full spectrum of dermatology through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.”
Jos Dijsselhof, CEO SIX, emphasized, “We are delighted to welcome Galderma to the SIX family. With this new addition, we are further strengthening our position as the leading go-to exchange in Europe for companies at the intersection of consumer and healthcare. I wish Galderma every success as a public company and look forward to partnering with Galderma on their future capital market endevours
Moulding is not shrewd business, he is a rich arrogant man child and unless you are prepared to wait 5 - 10 years I doubt very much whether you or I will see the shares back at 500p.
Welcome back crafty and thank you...
What Price THG Beauty?
The Spanish beauty giant plans to sell Class B shares at €22 to €24.50 each, which would value the group between €12.7bn and €13.9bn
https://cosmeticsbusiness.com/puig-sets-ipo-target-for-close-to-14-billion
Puig’s initial public offering (IPO) will start trading on the Spanish stock market on 3 May.
The Barcelona-based beauty group is aiming to raise approximately €3bn through the issuance of both new and existing shares.
This would enable 21% to 24% of the company’s stock to belong to outside investors, with the Puig family retaining a majority stake.
The group gave an expected range for its market capitalisation after the public offering of €12.7bn to €13.9bn, reported The Financial Times.
Puig and its founding family plan to sell Class B shares at €22 to €24.50 each, the company said in a filing with the Spanish securities regulator.
The IPO will involve around €1.25bn of new shares, while the Puig family is offering stock to about €1.36bn.
The number of shares will be determined by the final price of the IPO.
Puig, which owns Charlotte Tilbury, Kama Ayurveda and Rabanne, is capitalising on its growing momentum in the region’s equity markets.
The IPO will support the Spanish fragrance and cosmetics company’s expansion plans, particularly in Asia, and provide financial muscle for future growth.
Puig will list in Madrid and other Spanish stock exchanges with bankers at Goldman Sachs Bank Europe SE and J.P. Morgan SE leading the process.
Puig confirmed earlier this month its intention to float on the Madrid and other Spanish stock exchanges.
“It is important for any family business to have the right checks and balances in place, particularly during generational transitions,” said Marc Puig, Puig’s Chairman and CEO.
“We believe that the balance of being a family-owned company that is also subject to market accountability will allow us to better compete in the international beauty market during the next phase of the company’s development.”
This will be Spain’s largest IPO in nearly a decade, and if successful, could pave the way for more listings.
Puig is not the only beauty company looking to boost its momentum with an IPO listing this year.
Swiss skin care company Galderma started trading on the Swiss Exchange last month and shares have soared since.
Lead image An array of Charlotte Tilbury products.
Ste must be getting desperate with all this posting...that short Spread Bet must be hurting now..
Ste your arguments are increasingly weak i'm afraid.
- no capitial event - it will come when the deal is right - only upside to the SP
- no premium listing - there will be only one listing soon, so why bother - only upside to SP
- no material ingenuity win - agreed ingenuity wins disappoint, but more than reflected in SP
- ingenuity internal decline does not stack up - Don't agree, automation= cost out and dial back low margin customer acquisition to focus on margin. Nothing to see here
- nutrition decline for last 3 quarters - will return to growth post rebrand, plus partnerships in US
- beauty up through acquisition - Biossance low single digit contribution to Beauty growth according to call
- overall no real change/ improvement, as guided as FY just inline - Beauty is a big improvement, you told us it would be a revenue miss across the board
Ste 2000 moron. Still not prepared to tell people whether you're short or not? Come on, makes you look like a fool when you don't answer. If you're short and proud, shout it from the roof top and tell everyone!
Oh look at that.
The price just went up from 65.15 to 65.52 in a single trade. Do you want to write a post about how the price has gone up by 0.37p? Course you don't, because it doesn't fit your narrative.
Desperate.
Well how do they break even at 1.25bn revenue (of which 750m is internal) in next 4 years, if internal is declining?
Bob, that is how much emirates skycargo do, not Nut Group
anyone want to answer my points in previous message, or too factual for rampers lol
So let me see if I've got this right Ste:
The share price drops: Ste/GTC and the rest spam the board with an avalanche of negative posts.
The share price rises: Ste/GTC and the rest spam the board with an avalanche of negative posts.
Desperate.